Atlas Trials

A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects

Clinical trial NCT03305419 · COMPLETED

Trial details

NCT number
NCT03305419
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2017-10-11
Primary completion
2018-10-15
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.